Literature DB >> 21391000

Intent-to-randomize corrections for missing data resulting from run-in selection bias in clinical trials for chronic conditions.

Vance W Berger1, Behrang Vali.   

Abstract

In many clinical trials for chronic conditions a run-in period is used prior to randomization. Often, only those participants who meet certain criteria during the run-in phase go on to get randomized. The others, along with the information that they might have provided, are excluded from the study. This exclusion of the relevant response data from any subsequent study analysis can be considered as resulting in missing data; although quite common in practice, this approach has expectedly been shown to create a bias in favor of the active treatment when this active treatment is used during the run-in. Hence, many randomized clinical trials report overly optimistic results, with the extent of the bias depending in large part on how many otherwise eligible subjects were excluded due to the use of the run-in. If these biased trials are to contribute valid information to medical decision making, then the biases need to be corrected, and this involves accounting for all participants who were intended to be randomized. We propose specific imputation methods for doing so.

Entities:  

Mesh:

Year:  2011        PMID: 21391000     DOI: 10.1080/10543406.2011.550107

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  3 in total

1.  Conflicts of Interest, Selective Inertia, and Research Malpractice in Randomized Clinical Trials: An Unholy Trinity.

Authors:  Vance W Berger
Journal:  Sci Eng Ethics       Date:  2014-08-24       Impact factor: 3.525

Review 2.  Effect of xylitol versus sorbitol: a quantitative systematic review of clinical trials.

Authors:  Steffen Mickenautsch; Veerasamy Yengopal
Journal:  Int Dent J       Date:  2012-03-09       Impact factor: 2.607

3.  A SuperLearner Approach to Predict Run-In Selection in Clinical Trials.

Authors:  Corrado Lanera; Paola Berchialla; Giulia Lorenzoni; Aslihan Şentürk Acar; Valentina Chiminazzo; Danila Azzolina; Dario Gregori; Ileana Baldi
Journal:  Comput Math Methods Med       Date:  2022-09-10       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.